Traumatic Brain Injury Center of Excellence Warfighter Brain Health Research and Translation Support Services
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) is soliciting proposals for Traumatic Brain Injury Center of Excellence (TBICoE) Warfighter Brain Health Research and Translation Support Services. This opportunity seeks to advance the state of TBI science and clinical standards through comprehensive research, surveillance, clinical tool development, training, and cognitive monitoring. The contract is a Cost-Plus-Fixed-Fee (CPFF) type, with a period of performance including a base year and four option years. Proposals are due February 17, 2026, at 10:00 AM EDT.
Scope of Work
The contractor will provide all necessary personnel, equipment, and services to support TBICoE's mission. Key services include:
- Requirements-driven human clinical research investigations.
- TBI and brain health surveillance and outcomes analysis.
- Development, assessment, and implementation of clinical practice management guidelines and tools.
- TBI and brain health training, education, and dissemination programs.
- Cognitive monitoring program support. Contractors will act as Subject Matter Experts (SMEs) in TBI, facilitating research implementation, providing scientific leadership, conducting statistical analyses, and disseminating findings to various stakeholders. The work supports Congressionally mandated missions like the Warfighter Brain Health Initiative (WBHI) and the Cognitive Monitoring Program (CMP). Performance will be evaluated under a Quality Assurance Surveillance Plan (QASP).
Contract Details & Place of Performance
- Contract Type: Cost-Plus-Fixed-Fee (CPFF).
- Period of Performance: A 30-day transition-in, a base period, four 12-month option periods, and a 30-day transition-out.
- Set-Aside: None specified, but the solicitation emphasizes maximizing small business opportunities.
- Product Service Code: R499 (Other Professional Services).
- Place of Performance: Primarily TBICoE headquarters in Silver Spring, MD, with embedded personnel across various DHA facilities in the US and Germany (e.g., Landstuhl Regional Medical Center).
Submission Requirements & Deadlines
- Past Performance Volume Due: February 10, 2026, 10:00 AM EDT.
- Proposal Due: February 17, 2026, 10:00 AM EDT.
- Key Documents: The RFP package includes the Performance Work Statement (PWS), Past Performance Questionnaire (PPQ), Cost and Pricing Excel spreadsheet, and Contract Data Requirements Lists (CDRLs).
- Amendments: Amendment 3 (January 27, 2026) extended due dates, incorporated Government Q&A, a revised PWS, and additional documents (DD Form 254, Business Associate Agreement, Proposal Adequacy Checklist, Wage Determination).
- Clarifications: Resumes are not required; personnel qualifications can be addressed narratively. All services are non-personal. Federal Wide Assurance (FWA), Business Associate Agreement (BAA), and DD-254 are excluded from page count. An Organizational Conflicts of Interest (OCI) statement is required. Only 8.5x11 graphics are permitted. Proposal email submissions have a 20 MB file size limit.
Evaluation Factors
Proposals will be evaluated based on seven factors, in descending order of importance: Technical Approach/Capability, Management Capability, Personnel Qualifications, Past Performance Risk, Prior Experience, Small Business Participation Commitment/Plan, and Cost/Price. Non-price factors are significantly more important than price. Small Business Participation will be evaluated on a PASS/FAIL basis.